mol4239
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2013 (NCT01826201)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mol4239
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01826201 | Phase 2 | Mar 1, 2013 | International Dermatology Research Inc., Minnesota Clinical Study Center, Moleculin, LLC |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| International Dermatology Research Inc. | For profit | 1 | 0 | 1 | 2013 |
| Minnesota Clinical Study Center | For profit | 1 | 0 | 1 | 2013 |
| Moleculin, LLC | For profit | 1 | 1 | 1 | 2013 |
3 organizations
Page 1 / 1